CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

MANKIND PHARMA LTD.

NSE : MANKINDBSE : 543904ISIN CODE : INE634S01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE2537.05119.7 (+4.95 %)
PREV CLOSE () 2417.35
OPEN PRICE () 2417.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 57231
TODAY'S LOW / HIGH ()2404.00 2544.70
52 WK LOW / HIGH ()1909.9 2726.75
NSE2538.30124.1 (+5.14 %)
PREV CLOSE() 2414.20
OPEN PRICE () 2426.10
BID PRICE (QTY) 2538.30 (738)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 983998
TODAY'S LOW / HIGH() 2404.10 2543.50
52 WK LOW / HIGH ()1909.7 2716.5
ChairmanRamesh Juneja
Managing DirectorRajeev Juneja
Company SecretaryHitesh Kumar Jain
Non Executive Independent DirectorT P Ostwal
Vijaya Sampath
Bharat Anand
Vivek Kalra
Whole Time DirectorSheetal Arora
Satish Kumar Sharma
Incorporation Year : 03-07 1991

Registered Office :

Address : 208,Okhla Industrial Estate,Phase - 111 New Delhi,
Delhi-110020 .

Phone : 011-46846700 / 47476600

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX77094.07291.17 (0.38%)
NIFTY24102.9089.80 (0.37%)
Dow Jones 51564.7072.15 (0.14%)
Nasdaq 26517.93496.27 (1.91%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI